Exercise reduces IOP and axial length in young adults

Article

Exercise can reduce intraocular pressure (IOP), ocular pulse amplitude (OPA) and axial length (AXL).

An experiment featured in Eye has demonstrated that exercise can reduce intraocular pressure (IOP), ocular pulse amplitude (OPA) and axial length (AXL).

Dr S. A. Read et al., Contact Lens and Visual Optics Laboratory, School of Optometry, Queensland University of Technology, Australia, studied 20 young adults. Ten of the participants were myopic and 10 were emmetropic.

Ocular biometrics, blood pressure, pulse rate IOP and OPA were measured during a rest period of 20 minutes. All participants then underwent 10 minutes of low intensity exercise. The measurements were taken again straight after, as well as 5 and 10 minutes after, the exercise. The groups were measured several times to analyse the changes in the measured parameters.

Although there were no significant differences between the emmetropic and myopic patients, the findings revealed that exercise significantly decreased AXL, and reduced IOP and OPA for both groups. There was a positive correlation between AXL changes and IOP changes. Exercise is significantly effective in positively influencing AXL and IOP in the short-term.

Newsletter

Get the essential updates shaping the future of pharma manufacturing and compliance—subscribe today to Pharmaceutical Technology and never miss a breakthrough.

Recent Videos
Omer Trivizki, MD, MBA, a retina specialist from Tel Aviv Medical Center, speaks about VOY-101, a Novel, Complement-Modulating Gene Therapy for Geographic Atrophy at the American Society of Retina Specialists (ASRS) Annual Meeting
João Pedro Marques, MD, MSc, PhD discusses a retrospective study of 800 patients with inherited retinal diseases during the American Society of Retina Specialists (ASRS) annual meeting
Christine Curcio, PhD, of the University of Alabama at Birmingham Heersink School of Medicine, shares histology update and revised nomenclature for OCT with Sheryl Stevenson of the Eye Care Network and Ophthalmology Times
© 2025 MJH Life Sciences

All rights reserved.